Mark Ginestro

Principal at EY-Parthenon Life Sciences

Mark Ginestro is a partner in EY-Parthenon Strategy Practice, focusing on healthcare and life sciences. He has over 25 years of experience in growth strategy, portfolio strategy, M&A strategy, M&A diligence, acquisition integration and divestiture carve-out, brand strategy, pricing strategy, performance improvement, and organizational effectiveness. Ginestro has been involved in over 100 M&A transactions in life sciences throughout his career. He has experience in all aspects of life sciences, including medical devices, diagnostics, and healthcare distribution. He's authored many whitepapers and articles on various aspects of life sciences and is a frequent speaker at life sciences conferences.

1:45-2:45 p.m.

Thursday October 31,  2024

EY’s Pulse of the Industry—Presentation and Panel Discussion

A comprehensive look at the EY report’s findings with a focus on the trends driving change within the industry. From digital healthcare to regulatory shifts, this overview of the happenings within medtech will help shape expectations of what’s ahead for the sector. Following the presentation, a panel will focus on the points highlighted during the presentation and discuss their impact on the medtech sector. Using the report’s findings as the conversation pathway, this group of industry representatives will reflect on how factors such as digital health and regulatory changes, along with numerous other variables, will play a role in shaping healthcare technology.

Presented and moderated by Mark Ginestro.